The North America Preparative and Process Chromatography Market is poised for robust growth from 2024 to 2035, driven by increasing demand in pharmaceutical, biotechnology, and food & beverage sectors. The market size was valued at USD 2,450 Million in 2025 and is projected to reach USD 5,780 Million by 2035, registering a CAGR of 8.1% over the forecast period. Key players such as Thermo Fisher Scientific, Merck KGaA, and GE Healthcare are actively introducing innovations and collaborations to expand their market footprint.
The economic impact of tariffs on "North America Preparative and Process Chromatography Market".
Market Growth Drivers
Increasing Biopharmaceutical Production: The rising demand for biopharmaceuticals, including monoclonal antibodies and recombinant proteins, has pushed manufacturers to adopt advanced chromatography methods for efficient purification. Companies like Thermo Fisher Scientific are heavily investing in scalable process chromatography systems to streamline large-scale manufacturing and ensure high product purity and yield.
Technological Advancements in Chromatography Equipment: The integration of automation, digital control, and advanced detection techniques is enhancing chromatography workflows. For example, GE Healthcare recently introduced improved preparative chromatography systems with enhanced throughput and data analytics that help companies comply with stringent regulatory requirements and achieve operational excellence.
Market Trends
Adoption of Continuous Chromatography: There is a rising trend toward using continuous chromatography in process development and manufacturing to improve efficiency and productivity. Sartorius Stedim Biotech has reported increased uptake of its continuous chromatography products by North American pharmaceutical manufacturers looking to reduce costs and boost scalability.
Expansion of Contract Manufacturing Organizations (CMOs): The growth of contract manufacturing in North America has fueled demand for preparative and process chromatography solutions. Companies such as Lonza and Catalent are expanding chromatography-based purification capabilities to serve diverse client needs in biologics and biosimilars manufacturing.
Market Opportunity
Growing Biosimilars Market: The imminent wave of biosimilar approvals in North America presents significant opportunities for chromatography system manufacturers. Agilent Technologies is strategically collaborating with biosimilar producers to provide tailored preparative chromatography solutions for cost-effective drug development.
Rise in Personalized Medicine: The increasing focus on personalized medicine is driving demand for specialized chromatography techniques, enabling the separation and characterization of complex biological samples. Leading players are investing in innovative chromatography platforms to capture the personalized therapy market.
North America Preparative and Process Chromatography Market Revenue (USD Million), 2020-2035
The chart demonstrates a steady upward trajectory in market revenue for North America Preparative and Process Chromatography from 2020 to 2035. Starting at USD 1,300 Million in 2020, the market experiences a consistent growth driven by rising applications in pharmaceutical manufacturing, biotechnology innovations, and food safety testing. The revenue grows markedly from 2025 onwards, reaching approximately USD 5,780 Million by 2035, indicative of the increasing adoption of high-end and scalable chromatography solutions across key industry verticals. This growth trend reflects robust investments in R&D and capacity expansion efforts by leading market participants.
North America Preparative and Process Chromatography Market by Region Share (%) 2025
In 2025, the United States dominates the North America Preparative and Process Chromatography Market, accounting for approximately 76% share, reflecting its advanced biopharmaceutical manufacturing and R&D infrastructure. Canada follows with a 15% share, driven by supportive government initiatives and a growing bioscience sector. Mexico constitutes 6% as it witnesses increased investments in pharmaceutical production. The remaining 3% is split between smaller market participants in the region, such as Puerto Rico and Bermuda. This regional breakdown highlights the continued leadership of the US, with Canada and Mexico rapidly expanding their chromatography capabilities.
Recent Developments
In March 2024, Thermo Fisher Scientific unveiled a new suite of process-scale chromatography columns with enhanced resin lifespans and improved flow rates, designed to boost productivity for manufacturers of monoclonal antibodies and gene therapy products. This launch strengthens Thermo Fisher's process chromatography portfolio and supports large-scale bioprocessing workflows.
In April 2024, Merck KGaA announced the expansion of its chromatography resin production facility in Danvers, Massachusetts, with an investment exceeding USD 150 million. This development is aimed at meeting the rising demand for high-performance resins among North American biopharmaceutical companies and will support faster product delivery times.
In May 2024, GE Healthcare signed a strategic partnership agreement with a leading North American contract development and manufacturing organization (CDMO) to co-develop next-generation process chromatography systems leveraging AI-driven automation and advanced analytics, aiming to revolutionize downstream bioprocessing.
Press Releases